Portal de Periódicos da CAPES

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases

2024; Oxford University Press; Volume: 109; Issue: 12 Linguagem: Inglês

10.1210/clinem/dgae126

1945-7197

Marta Araujo‐Castro, Betina Biagetti, Edelmiro Menéndez Torre, Iría Novoa-Testa, Fernando Cordido, Eider Pascual‐Corrales, Víctor Rodríguez Berrocal, Fernando Guerrero‐Pérez, Almudena Vicente, Juan Carlos Percovich, Rogelio García Centeno, Laura González Fernández, María Dolores Ollero García, Ana Irigaray, María Dolores Moure Rodríguez, Cristina Novo‐Rodríguez, María Calatayud, Rocío Villar, Ignacio Bernabéu, Cristina Álvarez‐Escolá, Pamela Benítez Valderrama, Carmen Tenorio Jiménez, Pablo Abellán Galiana, Eva Venegas Moreno, Inmaculada González Molero, Pedro Iglesias, Concepción Blanco, Fernando Vidal-Ostos De Lara, Paz de Miguel, Elena López Mezquita, Felicia A. Hanzu, Ibán Aldecoa, Cristina Lamas, Silvia Aznar, Anna Aulinas, Anna Calabrese, Paola Gracia, José María Recio‐Córdova, Mariola Aviles, Diego Asensio-Wandosel, Miguel Sampedro, Ignacio Ruz‐Caracuel, Rosa Cámara, Miguel Paja, Carmen Fajardo, Mónica Marazuela, Manel Puig‐Domingo,

Adrenal and Paraganglionic Tumors

Few data exist about the clinical course of acromegaly, surgical and medical outcomes in patients with GH- and prolactin cosecreting pituitary adenomas (GH&PRL-PAs). Nevertheless, some series described a more aggressive clinic-radiological behavior than in growth hormone-secreting pituitary adenomas (GH-PAs).